Ginkgetin Alleviates Inflammation and Senescence by Targeting STING.
Abstract
Ginkgo biloba extract is reported to have therapeutic effects on aging-related disorders. However, the specific component responsible for this biological function and its mechanism of action remain largely unknown. This study finds that Ginkgetin, an active ingredient of Ginkgo biloba extract, can alleviate cellular senescence and improve pathologies in multiple tissues of aging mice. To reveal the molecular mechanism of Ginkgetin's anti-aging effect, a graph convolutional network-based drug "on-target" pathway prediction algorithm for prediction is employed. The results indicate that the cGAS-STING pathway may be a potential target for Ginkgetin. Subsequent cell biological and biophysical data confirmed that Ginkgetin directly binds to the carboxy-terminal domain of STING protein, thereby inhibiting STING activation and signal transduction. Furthermore, in vivo pharmacodynamic data showed that Ginkgetin effectively alleviates systemic inflammation in Trex1
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper investigates Ginkgetin, a component of Ginkgo biloba extract, and its effects on cellular senescence and inflammation, which are relevant to the biological mechanisms of aging. The study identifies a potential molecular target (the cGAS-STING pathway) for Ginkgetin's action, contributing to the understanding of how certain compounds may mitigate aging-related processes. However, while the findings are solid, they do not represent a major breakthrough or transformative advancement in the field, hence the moderate impact score.
Author of this paper? Send a correction.